AlzChem Group AG (ACT.DE)

Compare

94.00

-6.00

(-6.00%)

At close: April 4 at 5:37:55 PM GMT+2

AlzChem Group's (ETR:ACT) Upcoming Dividend Will Be Larger Than Last Year's

AlzChem Group AG ( ETR:ACT ) has announced that it will be increasing its dividend from last year's comparable payment...

Simply Wall St. 9 days ago

ALZCF
Investors Shouldn't Overlook AlzChem Group's (ETR:ACT) Impressive Returns On Capital

What are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...

Simply Wall St. 19 days ago

ALZCF
AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.80

AlzChem Group AG ( ETR:ACT ) will increase its dividend from last year's comparable payment on the 13th of May to...

Simply Wall St. last month

ALZCF
AlzChem Group's (ETR:ACT) investors will be pleased with their splendid 282% return over the last five years

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

Simply Wall St. last month

ALZCF
If EPS Growth Is Important To You, AlzChem Group (ETR:ACT) Presents An Opportunity

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Simply Wall St. 2 months ago

ALZCF
Is It Too Late To Consider Buying AlzChem Group AG (ETR:ACT)?

While AlzChem Group AG ( ETR:ACT ) might not have the largest market cap around , it saw a significant share price rise...

Simply Wall St. 3 months ago

ALZCF
AlzChem Group AG (ETR:ACT) has caught the attention of institutional investors who hold a sizeable 45% stake

Key Insights Given the large stake in the stock by institutions, AlzChem Group's stock price might be vulnerable to...

Simply Wall St. 4 months ago

ALZCF
AlzChem Group Third Quarter 2024 Earnings: EPS: €1.22 (vs €0.85 in 3Q 2023)

AlzChem Group ( ETR:ACT ) Third Quarter 2024 Results Key Financial Results Revenue: €132.7m (up 7.0% from 3Q 2023). Net...

Simply Wall St. 4 months ago

ALZCF
Is AlzChem Group AG's (ETR:ACT) Latest Stock Performance A Reflection Of Its Financial Health?

AlzChem Group's (ETR:ACT) stock is up by a considerable 26% over the past month. Given that the market rewards strong...

Simply Wall St. 5 months ago

ALZCF
The Return Trends At AlzChem Group (ETR:ACT) Look Promising

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...

Simply Wall St. 5 months ago

ALZCF
Estimating The Fair Value Of AlzChem Group AG (ETR:ACT)

Key Insights Using the 2 Stage Free Cash Flow to Equity, AlzChem Group fair value estimate is €38.37 With €40.80 share...

Simply Wall St. 6 months ago

ALZCF
AlzChem Group (ETR:ACT) shareholders have earned a 25% CAGR over the last five years

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if...

Simply Wall St. 6 months ago

ALZCF
Statutory Profit Doesn't Reflect How Good AlzChem Group's (ETR:ACT) Earnings Are

AlzChem Group AG ( ETR:ACT ) just reported healthy earnings but the stock price didn't move much. Our analysis suggests...

Simply Wall St. 7 months ago

ALZCF
AlzChem Group Second Quarter 2024 Earnings: EPS: €0.71 (vs €0.70 in 2Q 2023)

AlzChem Group ( ETR:ACT ) Second Quarter 2024 Results Key Financial Results Revenue: €139.9m (up 5.2% from 2Q 2023...

Simply Wall St. 7 months ago

ALZCF
What Does AlzChem Group AG's (ETR:ACT) Share Price Indicate?

AlzChem Group AG ( ETR:ACT ), is not the largest company out there, but it saw a significant share price rise of 45% in...

Simply Wall St. 9 months ago

ALZCF
It's Unlikely That AlzChem Group AG's (ETR:ACT) CEO Will See A Huge Pay Rise This Year

Key Insights AlzChem Group to hold its Annual General Meeting on 7th of May Salary of €315.0k is part of CEO Andreas...

Simply Wall St. 10 months ago

ALZCF
AlzChem Group's (ETR:ACT) Returns Have Hit A Wall

If you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...

Simply Wall St. 11 months ago

ALZCF
AlzChem Group AG's (ETR:ACT) Intrinsic Value Is Potentially 67% Above Its Share Price

Key Insights Using the 2 Stage Free Cash Flow to Equity, AlzChem Group fair value estimate is €72.16 AlzChem Group is...

Simply Wall St. 11 months ago

ALZCF

Performance Overview

Return	ACT.DE	DAX P (^GDAXI)
YTD	+64.91%	+3.68%
1-Year	+142.74%	+12.16%
3-Year	+369.05%	+42.18%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

AlzChem Group AG (ACT.DE)

AlzChem Group's (ETR:ACT) Upcoming Dividend Will Be Larger Than Last Year's

Investors Shouldn't Overlook AlzChem Group's (ETR:ACT) Impressive Returns On Capital

AlzChem Group's (ETR:ACT) Dividend Will Be Increased To €1.80

AlzChem Group's (ETR:ACT) investors will be pleased with their splendid 282% return over the last five years

If EPS Growth Is Important To You, AlzChem Group (ETR:ACT) Presents An Opportunity

Is It Too Late To Consider Buying AlzChem Group AG (ETR:ACT)?

AlzChem Group AG (ETR:ACT) has caught the attention of institutional investors who hold a sizeable 45% stake

AlzChem Group Third Quarter 2024 Earnings: EPS: €1.22 (vs €0.85 in 3Q 2023)

Is AlzChem Group AG's (ETR:ACT) Latest Stock Performance A Reflection Of Its Financial Health?

The Return Trends At AlzChem Group (ETR:ACT) Look Promising

Estimating The Fair Value Of AlzChem Group AG (ETR:ACT)

AlzChem Group (ETR:ACT) shareholders have earned a 25% CAGR over the last five years

Statutory Profit Doesn't Reflect How Good AlzChem Group's (ETR:ACT) Earnings Are

AlzChem Group Second Quarter 2024 Earnings: EPS: €0.71 (vs €0.70 in 2Q 2023)

What Does AlzChem Group AG's (ETR:ACT) Share Price Indicate?

It's Unlikely That AlzChem Group AG's (ETR:ACT) CEO Will See A Huge Pay Rise This Year

AlzChem Group's (ETR:ACT) Returns Have Hit A Wall

AlzChem Group AG's (ETR:ACT) Intrinsic Value Is Potentially 67% Above Its Share Price

Performance Overview